Previous 10 | Next 10 |
home / stock / dht.un:cc / dht.un:cc news
Canadian Investment Regulatory Organization Trading Halt - DHT.UN Canada NewsWire TORONTO , July 7, 2023 /CNW/ - The following issues have been halted by CIRO: Company: DRI Healthcare Trust TSX Symbol: DHT.UN All Issues: Yes Reason: Pending News H...
DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Net Sales of Orserdu™ (elacestrant) and Reiterates Long-Term Cash Receipts Outlook Canada NewsWire – Patent-protected exclusivity and uncapped deal structure offers attractive retur...
DRI Healthcare Trust Announces US$54.8 Million Debt Repayment from CTI BioPharma Corp. Canada NewsWire – Provides additional deployment capacity in pursuing attractive deals in high-quality pipeline – TORONTO , June 26, 2023 /CNW/ - DRI Heal...
DRI Healthcare Trust Announces Voting Results of AGM Canada NewsWire TORONTO , May 12, 2023 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") is pleased to announce results of voting at its annual general meeting ("AGM"...
DRI Healthcare Trust Reports First Quarter 2023 Results Canada NewsWire – Robust royalty transaction activity showcases ability to execute on attractive deals – – Continued strong performance of existing assets and financial results – ...
DRI Healthcare Trust to Host First Quarter Earnings Call and Webcast on May 12, 2023 Canada NewsWire TORONTO , April 27, 2023 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") announced today that it will hold a conference call to dis...
DRI Healthcare Trust Announces Sale of its TZIELD™ Royalty Interest to Sanofi for US$210 Million and Announces a US$20 Million Special Cash Distribution to Unitholders Canada NewsWire – Transaction will allow DHT to redeploy capital into new deals generating comp...
DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of TZIELD™ (teplizumab-mzwv) and Updates Long-Term Cash Receipts Outlook Canada NewsWire – Transaction adds a ground-breaking type 1 diabetes therapy to DRI's expanding portfo...
DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2022 Results Canada NewsWire – 2022 deployment of US$281 million continues to validate growth strategy – – Continued strong performance of existing assets and financial results – ...
DRI Healthcare Trust to Host Fourth Quarter and Full Year 2022 Earnings Call and Webcast on March 2, 2023 Canada NewsWire TORONTO , Feb. 16, 2023 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") announced today that it will hold a co...
News, Short Squeeze, Breakout and More Instantly...
Dri Healthcare Trust Company Name:
DHT.UN:CC Stock Symbol:
TSXC Market:
Dri Healthcare Trust Website:
DRI Healthcare Trust and DRI Capital Inc. Announce Executive Changes Canada NewsWire TORONTO , July 8, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") and DRI Capital Inc. ("DRI Healthcare"), the manager of the Trust, today announc...
DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 7, 2024 Canada NewsWire TORONTO , July 3, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") announces that it will hold a conference call to discuss its secon...
DRI Healthcare Trust Announces Acquisition of an Additional Royalty Interest in the Worldwide Sales of Xenpozyme® (olipudase alfa) for the Treatment of Acid Sphingomyelinase Deficiency Canada NewsWire – Transaction pushes total committed capital to over US$1 bill...